204 related articles for article (PubMed ID: 36473464)
1. Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs.
Kuznetcova I; Ostojić M; Gligorijević N; Aranđelović S; Arion VB
Inorg Chem; 2022 Dec; 61(50):20445-20460. PubMed ID: 36473464
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of Action.
Kuznetcova I; Bacher F; Alfadul SM; Tham MJR; Ang WH; Babak MV; Rapta P; Arion VB
Inorg Chem; 2022 Jul; 61(26):10167-10181. PubMed ID: 35713376
[TBL] [Abstract][Full Text] [Related]
3. Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.
Primik MF; Göschl S; Meier SM; Eberherr N; Jakupec MA; Enyedy É; Novitchi G; Arion VB
Inorg Chem; 2013 Sep; 52(17):10137-46. PubMed ID: 23952332
[TBL] [Abstract][Full Text] [Related]
4. Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells.
Ohui K; Stepanenko I; Besleaga I; Babak MV; Stafi R; Darvasiova D; Giester G; Pósa V; Enyedy EA; Vegh D; Rapta P; Ang WH; Popović-Bijelić A; Arion VB
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32961653
[TBL] [Abstract][Full Text] [Related]
5. Indolo[2,3-
Wittmann C; Dömötör O; Kuznetcova I; Spengler G; Reynisson J; Holder L; Miller GJ; Enyedy EA; Bai R; Hamel E; Arion VB
Dalton Trans; 2023 Jul; 52(29):9964-9982. PubMed ID: 37431840
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
9. Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity.
Kuhn PS; Cremer L; Gavriluta A; Jovanović KK; Filipović L; Hummer AA; Büchel GE; Dojčinović BP; Meier SM; Rompel A; Radulović S; Tommasino JB; Luneau D; Arion VB
Chemistry; 2015 Sep; 21(39):13703-13. PubMed ID: 26260662
[TBL] [Abstract][Full Text] [Related]
10. Highly Antiproliferative Latonduine and Indolo[2,3-
Wittmann C; Bacher F; Enyedy EA; Dömötör O; Spengler G; Madejski C; Reynisson J; Arion VB
J Med Chem; 2022 Feb; 65(3):2238-2261. PubMed ID: 35104137
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium(II)-Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria-Targeted Apoptotic Cell Death.
Sahu G; Patra SA; Lima S; Das S; Görls H; Plass W; Dinda R
Chemistry; 2023 Mar; 29(18):e202202694. PubMed ID: 36598160
[TBL] [Abstract][Full Text] [Related]
12. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
[TBL] [Abstract][Full Text] [Related]
13. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects.
Vančo J; Trávníček Z; Hošek J; Malina T; Dvořák Z
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299247
[TBL] [Abstract][Full Text] [Related]
15. Full Structural Characterization of Homoleptic Complexes of Diacetylcurcumin with Mg, Zn, Cu, and Mn: Cisplatin-level Cytotoxicity in Vitro with Minimal Acute Toxicity in Vivo.
Meza-Morales W; Estévez-Carmona MM; Alvarez-Ricardo Y; Obregón-Mendoza MA; Cassani J; Ramírez-Apan MT; Escobedo-Martínez C; Soriano-García M; Reynolds WF; Enríquez RG
Molecules; 2019 Apr; 24(8):. PubMed ID: 31018515
[TBL] [Abstract][Full Text] [Related]
16. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
17. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
18. Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition Activity.
Stepanenko I; Babak MV; Spengler G; Hammerstad M; Popovic-Bijelic A; Shova S; Büchel GE; Darvasiova D; Rapta P; Arion VB
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207929
[TBL] [Abstract][Full Text] [Related]
19. Copper(II) coordination compounds based on bis-hydrazones of 2,6-diacetylpyridine: synthesis, structure, and cytotoxic activity.
Kapustina AA; Tupolova YP; Popov LD; Vlasenko VG; Gishko KB; Berejnaya AG; Shcherbatykh AA; Golubeva YA; Klyushova LS; Lider EV; Lazarenko VA; Demidov OP; Knyazev PA; Bachurin SS; Nalbandyan VB; Shcherbakov IN
Dalton Trans; 2024 Feb; 53(7):3330-3347. PubMed ID: 38261350
[TBL] [Abstract][Full Text] [Related]
20. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
Afsan Z; Roisnel T; Tabassum S; Arjmand F
Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
